Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Aurinia Pharmaceuticals Inc. quarterly Deferred Income Tax Assets, Net in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
Aurinia Pharmaceuticals Inc. Deferred Income Tax Assets, Net for the quarter ending 31 Dec 2025 was $176,194,000.
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.